Safety and Efficacy of Combigan® Ophthalmic Solution in Korea

CompletedOBSERVATIONAL

Enrollment

732

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

Glaucoma, Open-AngleOcular Hypertension

Interventions

DRUG

brimonidine tartrate/timolol maleate Ophthalmic Solution

brimonidine tartrate/timolol maleate (Combigan®) Ophthalmic Solution as per local standard of care in clinical practice.

Trial Locations (1)

Seoul